MediWound (MDWD) Non Operating Income (2013 - 2026)
MediWound (MDWD) posted quarterly Non Operating Income of $690000.0 for Q4 2025, down 68.79% year-over-year from $2.2 million in Q4 2024, and down 82.42% quarter-over-quarter from $3.9 million in Q3 2025.
MediWound (MDWD) Non Operating Income (2013 - 2026) Analysis & Trends
MediWound's Non Operating Income history runs 13 years deep, the most recent figure standing at $690000.0 for Q4 2025.
- In Q4 2025, Non Operating Income fell 68.79% year-over-year to $690000.0; the TTM figure through Dec 2025 stood at $1.6 million (up 114.46% YoY), while the FY2025 annual figure was $1.6 million, up 114.46% from the prior year.
- Non Operating Income for Q4 2025 stood at $690000.0, down from $3.9 million in the prior quarter.
- The five-year high for Non Operating Income was $4.9 million in Q2 2023, with the low at -$9.5 million in Q4 2022.
- The 5-year median for Non Operating Income is -$379000.0 (2021), against an average of -$696350.0.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income sank 1398.43% in 2022, then jumped 830.03% in 2023.
- MediWound's Non Operating Income stood at -$635000.0 in 2021, then tumbled by 1398.43% to -$9.5 million in 2022, then soared by 123.87% to $2.3 million in 2023, then dropped by 2.64% to $2.2 million in 2024, then sank by 68.79% to $690000.0 in 2025.
- Business Quant data shows MDWD's Non Operating Income at $690000.0 in Q4 2025, $3.9 million in Q3 2025, and -$7.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.10 Mn |
| Dec 31, 2025 | 690,000.00 |
| Sep 30, 2025 | 3.93 Mn |
| Jun 30, 2025 | -7.56 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | -5.18 Mn |
| Jun 30, 2024 | -1.82 Mn |
| Mar 31, 2024 | -5.97 Mn |
| Dec 31, 2023 | 2.27 Mn |
| Sep 30, 2023 | 877,000.00 |
| Jun 30, 2023 | 4.94 Mn |
| Mar 31, 2023 | 676,000.00 |
| Dec 31, 2022 | -9.52 Mn |
| Sep 30, 2022 | -684,000.00 |
| Jun 30, 2022 | -676,000.00 |
| Mar 31, 2022 | -301,000.00 |
| Dec 31, 2021 | -635,000.00 |
| Sep 30, 2021 | -457,000.00 |
| Jun 30, 2021 | -281,000.00 |